CIK 0001130598
- Non-accelerated filer
- Smaller reporting company
Traws Pharma, Inc.
Sign in to watch- Ticker
- TRAW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 267-759-3680
- Business address
- 12 PENNS TRAIL, NEWTOWN, PA, 18940
- Former names
- Onconova Therapeutics, Inc., ONCONOVA THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 26 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-12-18 | Guerin Mark Patrick Chief Accounting Officer | Grant or award · Stock Option (right to purchase) | +25,000 | 25,000 | ||
| 2014-07-07 | Hoffman Michael B Director | Exercise or conversion | +18,754 | $2.67 | $50K | 18,754 |
| 2014-07-07 | Hoffman Michael B Director | Exercise or conversion · Stock Option (right to purchase) | −18,754 | 0 | ||
| 2014-05-22 | VANLENT ANNE Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2014-05-22 | Reddy E Premkumar Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2014-05-22 | GROOPMAN JEROME Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2014-05-22 | MEHTA VIREN Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2014-05-22 | Bienen Henry S Director | Grant or award · Stock Option (right to purchase) | +10,000 | 10,000 | ||
| 2014-05-22 | Hoffman Michael B Director | Grant or award · Stock Option (right to purchase) | +13,000 | 13,000 | ||
| 2014-05-02 | Reddy E Premkumar Director | Exercise or conversion | +27,084 | $1.33 | $36K | 1,337,838 |
| 2014-05-02 | Reddy E Premkumar Director | Exercise or conversion · Common Stock Option (right to buy) | −27,084 | 0 | ||
| 2014-02-21 | Michael & Jane Hoffman 2013 Descendants 10% owner | Purchase | +71,740 | $8.91 | $639K | 4,518,275 |
| 2014-02-21 | Hoffman Michael B Director | Purchase | +71,740 | $8.91 | $639K | 4,518,275 |
| 2014-02-20 | Michael & Jane Hoffman 2013 Descendants 10% owner | Purchase | +71,740 | $8.03 | $576K | 4,446,535 |
| 2014-02-20 | Hoffman Michael B Director | Purchase | +71,740 | $8.03 | $576K | 4,446,535 |
| 2014-02-10 | Kumar Ramesh President and CEO | Exercise or conversion | +20,000 | $6.00 | $120K | 296,500 |
| 2014-02-10 | Kumar Ramesh President and CEO | Sale | −20,000 | $15.11 | $302K | 276,500 |
| 2014-02-10 | Kumar Ramesh President and CEO | Exercise or conversion · Stock Option (right to buy) | −20,000 | 16,739 | ||
| 2014-02-07 | Kumar Ramesh President and CEO | Exercise or conversion | +13,543 | $6.00 | $81K | 290,043 |
| 2014-02-07 | Kumar Ramesh President and CEO | Exercise or conversion · Stock Option (right to buy) | −13,543 | 36,739 |
Page 21 of 23 · 449 trades